Nutritional Ketone Supplement ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
317三頭酵素欠損症1

317. 三頭酵素欠損症


臨床試験数 : 4 薬物数 : 9 - (DrugBank : 4) / 標的遺伝子数 : 1 - 標的パスウェイ数 : 1
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05411835
(ClinicalTrials.gov)
August 1, 202227/5/2022Oral Ketones and Exercise Among Patients With Long-chain Fatty Acid Oxidation DisordersSafety and Tolerability of Oral Ketones and Exercise Among Patients With Long-chain Fatty Acid Oxidation DisordersLong-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency;Carnitine Palmitoyltransferase Deficiency 2;Very Long Chain Acyl Coa Dehydrogenase Deficiency;Trifunctional Protein DeficiencyDietary Supplement: Nutritional Ketone Supplement;Dietary Supplement: Isocaloric Placebo SupplementOregon Health and Science UniversityNULLRecruiting18 YearsN/AAll5Early Phase 1United States